5 things to know before the stock market opens Tuesday

Global markets rallied on Monday, with major U.S. indices gaining nearly 1%, as hopes for de-escalation in the Middle East grew after Iran's retaliatory strike caused no casualties and President Trump downplayed its significance, leading to a 7% drop in crude oil prices. Concurrently, Tesla shares jumped 8% following the debut of its Model Y robotaxi, while Hims & Hers plummeted almost 35% after Novo Nordisk terminated their partnership over concerns about the telehealth provider selling cheaper alternatives to Wegovy.

Analysis

U.S. equity markets demonstrated significant resilience, with major indices like the Dow and S&P 500 rising by approximately 0.9%, as investors priced in a contained geopolitical conflict in the Middle East. This optimism stems from Iran's retaliatory missile strike causing no casualties and being characterized by the U.S. President as a 'very weak response,' which subsequently drove a sharp 7% decline in both U.S. and Brent crude oil prices to their lowest levels since June 13. The market appears to be discounting the risk of major oil supply disruptions through shipping lanes like the Strait of Hormuz. On a micro level, Tesla (TSLA) shares surged 8% following the weekend debut of its Model Y robotaxi, a key event for its long-term autonomous vehicle strategy, though the launch was limited and is already facing regulatory scrutiny over unspecified incidents. In the pharmaceutical sector, Hims & Hers (HIMS) stock plummeted nearly 35% after Novo Nordisk terminated its partnership to supply the weight-loss drug Wegovy, citing concerns over HIMS promoting cheaper, non-branded alternatives, highlighting the significant platform risk for telehealth companies dependent on such agreements.

Key Decisions for Investors

• Given the 7% drop in oil prices on de-escalation hopes, investors should monitor Middle East developments closely, as any re-escalation could rapidly reverse these gains and reintroduce a significant risk premium to energy assets.
• The 8% rally in Tesla underscores the market's high sensitivity to its autonomy narrative, but investors should weigh this enthusiasm against the reality of a limited robotaxi rollout and emerging regulatory oversight, which could delay meaningful revenue generation.
• The 35% collapse in Hims & Hers' stock after losing the Wegovy partnership serves as a stark reminder of the concentration risk in telehealth business models; conversely, Novo Nordisk's move to protect its brand integrity may reinforce its long-term market position and pricing power in the lucrative obesity drug market.